SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

LG Display Co., Ltd. – ‘20-F’ for 12/31/20 – ‘EX-1.1’

On:  Thursday, 4/29/21, at 8:24am ET   ·   For:  12/31/20   ·   Accession #:  1193125-21-138471   ·   File #:  1-32238

Previous ‘20-F’:  ‘20-F’ on 4/29/20 for 12/31/19   ·   Next:  ‘20-F’ on 4/28/22 for 12/31/21   ·   Latest:  ‘20-F’ on 4/29/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/21  LG Display Co., Ltd.              20-F       12/31/20  181:24M                                    Donnelley … Solutions/FA

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual or Annual-Transition Report by a Foreign     HTML   2.14M 
                Non-Canadian Issuer                                              
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    142K 
 3: EX-2.6      Plan of Acquisition, Reorganization, Arrangement,   HTML    116K 
                Liquidation or Succession                                        
 6: EX-13.1     Annual or Quarterly Report to Security Holders      HTML     51K 
 7: EX-13.2     Annual or Quarterly Report to Security Holders      HTML     51K 
 4: EX-12.1     Statement re: the Computation of Ratios             HTML     54K 
 5: EX-12.2     Statement re: the Computation of Ratios             HTML     54K 
14: R1          Cover Page                                          HTML    103K 
15: R2          Consolidated Statements of Financial Position       HTML    161K 
16: R3          Consolidated Statements of Comprehensive Income     HTML    141K 
                (Loss)                                                           
17: R4          Consolidated Statements of Changes in Equity        HTML     87K 
18: R5          Consolidated Statements of Cash Flows               HTML    243K 
19: R6          Reporting Entity                                    HTML    168K 
20: R7          Basis of Presenting Financial Statements            HTML     73K 
21: R8          Summary of Significant Accounting Policies          HTML    304K 
22: R9          Cash and Cash Equivalents and Deposits in Banks     HTML     75K 
23: R10         Trade Accounts and Notes Receivable, Other          HTML    134K 
                Accounts Receivable and Other Current Assets                     
24: R11         Other Financial Assets                              HTML     90K 
25: R12         Inventories                                         HTML     68K 
26: R13         Investments in Equity Accounted Investees           HTML    181K 
27: R14         Property, Plant and Equipment                       HTML    197K 
28: R15         Intangible Assets and Non-financial Assets          HTML    268K 
                Impairment                                                       
29: R16         Financial Liabilities                               HTML    174K 
30: R17         Employee Benefits                                   HTML    159K 
31: R18         Provisions                                          HTML     83K 
32: R19         Contingent Liabilities and Commitments              HTML    133K 
33: R20         Capital and Reserves                                HTML     85K 
34: R21         Geographic and Other Information                    HTML    103K 
35: R22         The Nature of Expenses and Others                   HTML     80K 
36: R23         Selling and Administrative Expenses                 HTML     78K 
37: R24         Personnel Expenses                                  HTML     66K 
38: R25         Other Income and Other Expenses                     HTML     86K 
39: R26         Finance Income and Finance Costs                    HTML     99K 
40: R27         Income Tax Expense (Benefit)                        HTML    140K 
41: R28         Deferred Tax Assets and Liabilities                 HTML    139K 
42: R29         Loss Per Share Attributable to Owners of the        HTML     65K 
                Controlling Company                                              
43: R30         Financial Risk Management                           HTML    412K 
44: R31         Leases                                              HTML    128K 
45: R32         Changes in liabilities arising from financing       HTML     78K 
                activities                                                       
46: R33         Related Parties and Others                          HTML    376K 
47: R34         Supplemental Cash Flow Information                  HTML     61K 
48: R35         Summary of Significant Accounting Policies          HTML    348K 
                (Policies)                                                       
49: R36         Reporting Entity (Tables)                           HTML    166K 
50: R37         Summary of Significant Accounting Policies          HTML     82K 
                (Tables)                                                         
51: R38         Cash and Cash Equivalents and Deposits in Banks     HTML     74K 
                (Tables)                                                         
52: R39         Trade Accounts and Notes Receivable, Other          HTML    142K 
                Accounts Receivable and Other Current Assets                     
                (Tables)                                                         
53: R40         Other Financial Assets (Tables)                     HTML     89K 
54: R41         Inventories (Tables)                                HTML     68K 
55: R42         Investments in Equity Accounted Investees (Tables)  HTML    186K 
56: R43         Property, Plant and Equipment (Tables)              HTML    197K 
57: R44         Intangible Assets and Non-financial Assets          HTML    262K 
                Impairment (Tables)                                              
58: R45         Financial Liabilities (Tables)                      HTML    181K 
59: R46         Employee Benefits (Tables)                          HTML    172K 
60: R47         Provisions (Tables)                                 HTML     82K 
61: R48         Contingent Liabilities and Commitments (Tables)     HTML    121K 
62: R49         Capital and Reserves (Tables)                       HTML     82K 
63: R50         Geographic and Other Information (Tables)           HTML    104K 
64: R51         The Nature of Expenses and Others (Tables)          HTML     79K 
65: R52         Selling and Administrative Expenses (Tables)        HTML     77K 
66: R53         Personnel Expenses (Tables)                         HTML     65K 
67: R54         Other Income and Other Expenses (Tables)            HTML     87K 
68: R55         Finance Income and Finance Costs (Tables)           HTML    100K 
69: R56         Income Tax Expense (Benefit) (Tables)               HTML    141K 
70: R57         Deferred Tax Assets and Liabilities (Tables)        HTML    139K 
71: R58         Loss Per Share Attributable to Owners of the        HTML     62K 
                Controlling Company (Tables)                                     
72: R59         Financial Risk Management (Tables)                  HTML    406K 
73: R60         Leases - (Tables)                                   HTML    137K 
74: R61         Changes in liabilities arising from financing       HTML     78K 
                activities (Tables)                                              
75: R62         Related Parties and Others (Tables)                 HTML    373K 
76: R63         Supplemental Cash Flow Information (Tables)         HTML     60K 
77: R64         Reporting Entity - Additional Information (Detail)  HTML     73K 
78: R65         Reporting Entity - Summary of Consolidated          HTML    188K 
                Subsidiaries (Detail)                                            
79: R66         Reporting Entity - Summary of Consolidated          HTML     65K 
                Subsidiaries (Parenthetical) (Detail)                            
80: R67         Reporting Entity - Summary of Information of        HTML    121K 
                Subsidiaries having Significant Non controlling                  
                Interests (Detail)                                               
81: R68         Summary of Significant Accounting Policies -        HTML     60K 
                Schedule of Impacts on condensed consolidated                    
                interim financial statements (Detail)                            
82: R69         Summary of Significant Accounting Policies -        HTML     62K 
                Summary of measuring lease liabilities (Details)                 
83: R70         Summary of Significant Accounting Policies -        HTML     54K 
                Additional Information (Detail)                                  
84: R71         Summary of Significant Accounting Policies -        HTML     68K 
                Estimated Useful Lives of Property, Plant and                    
                Equipment (Detail)                                               
85: R72         Summary of Significant Accounting Policies -        HTML     71K 
                Estimated Useful Lives of Intangible Assets, Other               
                Than Goodwill (Detail)                                           
86: R73         Cash and Cash Equivalents and Deposits in Banks -   HTML     72K 
                Summary of Cash and Cash Equivalents and Deposits                
                in Bank (Detail)                                                 
87: R74         Trade Accounts and Notes Receivable, Other          HTML     58K 
                Accounts Receivable and Other Current Assets -                   
                Summary of Trade Accounts and Notes Receivable                   
                (Detail)                                                         
88: R75         Trade Accounts and Notes Receivable, Other          HTML     61K 
                Accounts Receivable and Other Current Assets -                   
                Summary of Other Accounts Receivable (Detail)                    
89: R76         Trade Accounts and Notes Receivable, Other          HTML     56K 
                Accounts Receivable and Other Current Assets -                   
                Additional Information (Detail)                                  
90: R77         Trade Accounts and Notes Receivable, Other          HTML     82K 
                Accounts Receivable and Other Current Assets -                   
                Aging of Trade Accounts and Notes Receivable,                    
                Other Accounts Receivable and Long-term Non-trade                
                Receivable (Detail)                                              
91: R78         Trade Accounts and Notes Receivable, Other          HTML     63K 
                Accounts Receivable and Other Current Assets -                   
                Movement in Allowance for Impairment in Respect of               
                Trade Accounts and Notes Receivable and Other                    
                Accounts Receivable (Detail)                                     
92: R79         Trade Accounts and Notes Receivable, Other          HTML     61K 
                Accounts Receivable and Other Current Assets -                   
                Summary of Other Assets (Detail)                                 
93: R80         Other Financial Assets - Summary of Other           HTML     90K 
                Financial Assets (Detail)                                        
94: R81         Inventories - Summary of Inventories (Detail)       HTML     63K 
95: R82         Inventories - Inventories Recognized as Cost of     HTML     56K 
                Sales and Inventory Write-downs Included in Cost                 
                of Sales (Detail)                                                
96: R83         Investments in Equity Accounted Investees -         HTML     98K 
                Summary of Associates (Detail)                                   
97: R84         Investments in Equity Accounted Investees -         HTML     91K 
                Summary of Associates (Parenthetical) (Detail)                   
98: R85         Investments in Equity Accounted Investees -         HTML     63K 
                Additional Information (Detail)                                  
99: R86         Investments in Equity Accounted Investees -         HTML     94K 
                Summary of Financial Information of Significant                  
                Associate (Detail)                                               
100: R87         Investments in Equity Accounted Investees -         HTML     72K  
                Reconciliation from Financial Information of                     
                Significant Associate to its Carrying Value in                   
                Consolidated Financial Statements (Detail)                       
101: R88         Investments in Equity Accounted Investees -         HTML     71K  
                Summary of Financial Information of Other                        
                Associates, in Aggregate (Detail)                                
102: R89         Investments in Equity Accounted Investees -         HTML     78K  
                Changes in Investments in Associates and a Joint                 
                Venture Accounted for Using The Equity Method                    
                (Detail)                                                         
103: R90         Property, Plant and Equipment - Changes in          HTML    147K  
                Property, Plant and Equipment (Detail)                           
104: R91         Property, Plant and Equipment - Changes in          HTML     63K  
                Property, Plant and Equipment (Parenthetical)                    
                (Detail)                                                         
105: R92         Property, Plant and Equipment - Capitalized         HTML     56K  
                Borrowing Costs and Capitalization Rate (Detail)                 
106: R93         Intangible Assets and Non-financial Assets          HTML    161K  
                Impairment - Changes in Intangible Assets (Detail)               
107: R94         Intangible Assets and Non-financial Assets          HTML     64K  
                Impairment - Changes in Intangible Assets                        
                (Parenthetical) (Detail)                                         
108: R95         Intangible Assets and Non-financial Assets          HTML     64K  
                Impairment - Summary of Development Costs (Detail)               
109: R96         Intangible Assets and Non-financial Assets          HTML     65K  
                Impairment - Additional Information (Detail)                     
110: R97         Intangible Assets and Non-financial Assets          HTML     63K  
                Impairment - Impairment assessment (Detail)                      
111: R98         Intangible Assets and Non-financial Assets          HTML     79K  
                Impairment - Impairment assessment (Parenthetical)               
                (Detail)                                                         
112: R99         Financial Liabilities - Summary of Financial        HTML     82K  
                Liabilities (Detail)                                             
113: R100        Financial Liabilities - Summary of Short-term       HTML     71K  
                Borowings (Detail)                                               
114: R101        Financial Liabilities - Summary of Long-term        HTML     85K  
                Borrowings (Detail)                                              
115: R102        Financial Liabilities - Summary of Long-term        HTML     61K  
                Borrowings (Parenthetical) (Detail)                              
116: R103        Financial Liabilities - Details of Bonds Issued     HTML    106K  
                and Outstanding (Detail)                                         
117: R104        Financial Liabilities - Details of the convertible  HTML     78K  
                Bonds Issued and Outstanding (Detail)                            
118: R105        Employee Benefits - Net Defined Benefit             HTML     62K  
                Liabilities (Detail)                                             
119: R106        Employee Benefits - Changes in Present Value of     HTML     76K  
                Defined Benefit Obligations (Detail)                             
120: R107        Employee Benefits - Additional Information          HTML     53K  
                (Detail)                                                         
121: R108        Employee Benefits - Changes in Fair Value of Plan   HTML     69K  
                Assets (Detail)                                                  
122: R109        Employee Benefits - Details of Plan Assets          HTML     53K  
                (Detail)                                                         
123: R110        Employee Benefits - Expenses Recognized in Profit   HTML     70K  
                or Loss and Line Items Included in Consolidated                  
                Statements of Comprehensive Income (Detail)                      
124: R111        Employee Benefits - Remeasurements of Net Defined   HTML     77K  
                Benefit Liabilities (Assets) Included in Other                   
                Comprehensive Income (Loss) (Detail)                             
125: R112        Employee Benefits - Principal Actuarial             HTML     71K  
                Assumptions (Detail)                                             
126: R113        Employee Benefits - Amounts of Defined Benefit      HTML     61K  
                Obligations Affected by Reasonably Possible                      
                Changes to Respective Relevant Actuarial                         
                Assumptions (Detail)                                             
127: R114        Provisions - Changes in Provisions (Detail)         HTML     72K  
128: R115        Contingent Liabilities and Commitments -            HTML     95K  
                Additional Information (Detail)                                  
129: R116        Contingent Liabilities and Commitments - Maximum    HTML    109K  
                Amount of Accounts Receivables Sales and Amount of               
                Sold Accounts Receivables before Maturity by                     
                Contract (Detail)                                                
130: R117        Contingent Liabilities and Commitments - Letters    HTML     72K  
                of Credit from Financial Institutions and                        
                Respective Credit Limits (Detail)                                
131: R118        Capital and Reserves - Additional Information       HTML     57K  
                (Detail)                                                         
132: R119        Capital and Reserves - Summary of Reserves at       HTML     58K  
                Reporting Date (Detail)                                          
133: R120        Capital and Reserves - Movement in Reserves         HTML     62K  
                (Detail)                                                         
134: R121        Geographic and Other Information - Revenue and      HTML     84K  
                Non-current Assets by Geography (Detail)                         
135: R122        Geographic and Other Information - Additional       HTML     65K  
                Information (Detail)                                             
136: R123        Geographic and Other Information - Revenue by       HTML     63K  
                Product and Services (Detail)                                    
137: R124        The Nature of Expenses and Others - Classification  HTML     89K  
                of Expenses by Nature (Detail)                                   
138: R125        Selling and Administrative Expenses - Details of    HTML     87K  
                Selling and Administrative Expenses (Detail)                     
139: R126        Selling and Administrative Expenses - Details of    HTML     55K  
                Selling and Administrative Expenses                              
                (Parenthetical) (Detail)                                         
140: R127        Personnel Expenses - Disclosure of Details of       HTML     63K  
                Personnel Expenses (Detail)                                      
141: R128        Personnel Expenses - Disclosure of Details of       HTML     55K  
                Personnel Expenses (Parenthetical) (Detail)                      
142: R129        Other Income and Other Expenses - Summary of Other  HTML     69K  
                Income (Detail)                                                  
143: R130        Other Income and Other Expenses - Summary of Other  HTML     72K  
                Expenses (Detail)                                                
144: R131        Finance Income and Finance Costs - Summary of       HTML     96K  
                Finance Income and Finance Costs recognized in                   
                Profit or Loss (Detail)                                          
145: R132        Finance Income and Finance Costs - Finance Income   HTML     56K  
                and Costs Recognized in Other Comprehensive Income               
                or Loss (Detail)                                                 
146: R133        Income Tax Expense (Benefit) - Details of Income    HTML     71K  
                Tax Expense (Benefit) Recognized in Profit                       
                (Detail)                                                         
147: R134        Income Tax Expense (Benefit) - Income Taxes         HTML     85K  
                Recognized Directly in Other Comprehensive Income                
                (Detail)                                                         
148: R135        Income Tax Expense (Benefit) - Reconciliation of    HTML     89K  
                Actual Effective Tax Rate (Detail)                               
149: R136        Income Tax Expense (Benefit) - Additional           HTML     54K  
                Information (Detail)                                             
150: R137        Deferred Tax Assets and Liabilities - Additional    HTML     54K  
                Information (Detail)                                             
151: R138        Deferred Tax Assets and Liabilities - Tax Credit    HTML     65K  
                Carryforwards Expiration Dates (Detail)                          
152: R139        Deferred Tax Assets and Liabilities - Details of    HTML     94K  
                Deferred Tax Assets and Liabilities (Detail)                     
153: R140        Deferred Tax Assets and Liabilities - Changes in    HTML    100K  
                Deferred Tax Assets and Liabilities (Detail)                     
154: R141        Loss Per Share Attributable to Owners of the        HTML     58K  
                Controlling Company - Summary of Basic Earnings                  
                per Share (Detail)                                               
155: R142        Loss Per Share Attributable to Owners of the        HTML     52K  
                Controlling Company - Additional Information                     
                (Detail)                                                         
156: R143        Financial Risk Management - Exposure to Foreign     HTML     91K  
                Currency Risk Based on Notional Amounts (Detail)                 
157: R144        Financial Risk Management - Average Exchange Rates  HTML     75K  
                Applied during Reporting Periods (Detail)                        
158: R145        Financial Risk Management - Summary of Changes in   HTML     82K  
                Equity and Profit or Loss (Detail)                               
159: R146        Financial Risk Management - Additional Information  HTML     57K  
                (Detail)                                                         
160: R147        Financial Risk Management - Interest Rate Profile   HTML     66K  
                of Interest-bearing Financial Instruments (Detail)               
161: R148        Financial Risk Management - Equity and Profit or    HTML     65K  
                Loss Sensitivity Analysis for Variable Rate                      
                Instruments (Detail)                                             
162: R149        Financial Risk Management - Maximum Exposure to     HTML     98K  
                Credit Risk of Financial Assets (Detail)                         
163: R150        Financial Risk Management - Contractual Maturities  HTML    106K  
                of Financial Liabilities, Including Estimated                    
                Interest Payments (Detail)                                       
164: R151        Financial Risk Management - Summary of Other        HTML     56K  
                Accounts Payable (Detail)                                        
165: R152        Financial Risk Management - Summary of Capital      HTML     66K  
                Management (Detail)                                              
166: R153        Financial Risk Management - Fair Values of          HTML    117K  
                Financial Assets and Liabilities, Together with                  
                Carrying Amounts Shown in Consolidated Statement                 
                of Financial Position (Detail)                                   
167: R154        Financial Risk Management - Fair Value Hierarchy    HTML     72K  
                Classifications of Financial Instruments Measured                
                at Fair Value (Detail)                                           
168: R155        Financial Risk Management - Fair Value Hierarchy    HTML     76K  
                Classifications, Valuation Technique and Inputs                  
                for Fair Value Measurements of Financial                         
                Instruments not Measured at Fair Value (Detail)                  
169: R156        Leases - Disclosure Of Quantitative Information     HTML     98K  
                About Right of use Assets Explanatory (Details)                  
170: R157        Leases - Disclosure of lease related income and     HTML     61K  
                expenses (Details)                                               
171: R158        Leases - Schedule of lease liabilities (Details)    HTML     60K  
172: R159        Leases - Schedule of maturity Analysis of leases    HTML     72K  
                receivable (Details)                                             
173: R160        Leases - Additional Information (Details)           HTML     53K  
174: R161        Changes in Liabilities Arising from Financing       HTML     83K  
                Activities - Summary of Changes in Liabilities                   
                Arising from Financing Activities (Detail)                       
175: R162        Related Parties and Others - Significant            HTML    186K  
                Transactions, Trade Accounts and Notes Receivable                
                and Payable Occurred in Normal Course of Business                
                with Related Parties (Detail)                                    
176: R163        Related Parties and Others - Details of             HTML     59K  
                Significant Cash Transactions of Loans and                       
                Collection of Loans Occurred in Normal Course of                 
                Business with Related Parties (Detail)                           
177: R164        Related Parties and Others - Compensation Costs of  HTML     58K  
                Key Management (Detail)                                          
178: R165        Supplemental Cash Flow Information - Summary of     HTML     56K  
                Non-cash Investing and Financing Activities                      
                (Detail)                                                         
180: XML         IDEA XML File -- Filing Summary                      XML    361K  
179: EXCEL       IDEA Workbook of Financial Reports                  XLSX    271K  
 8: EX-101.INS  XBRL Instance -- lpl-20201231                        XML   9.84M 
10: EX-101.CAL  XBRL Calculations -- lpl-20201231_cal                XML    367K 
11: EX-101.DEF  XBRL Definitions -- lpl-20201231_def                 XML   1.63M 
12: EX-101.LAB  XBRL Labels -- lpl-20201231_lab                      XML   2.61M 
13: EX-101.PRE  XBRL Presentations -- lpl-20201231_pre               XML   2.31M 
 9: EX-101.SCH  XBRL Schema -- lpl-20201231                          XSD    487K 
181: ZIP         XBRL Zipped Folder -- 0001193125-21-138471-xbrl      Zip    527K  


‘EX-1.1’   —   Underwriting Agreement or Conflict Minerals Report


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-1.1  

Exhibit 1.1

ARTICLES OF INCORPORATION

OF

LG DISPLAY CO., LTD.

Amended on August 11, 2000

Amended on March 21, 2001

Amended on March 19, 2004

Amended on May 4, 2004

Amended on June 23, 2004

Amended on March 23, 2005

Amended on February 28, 2007

Amended on February 29, 2008

Amended on March 13, 2009

Amended on March 12, 2010

Amended on March 11, 2011

Amended on March 8, 2013

Amended on March 15, 2019

Amended on March 23, 2021

CHAPTER I.         GENERAL PROVISIONS

 

Article 1.

(Trade Name)

The name of the company shall be “EL-GI DISPLAY CHUSIK HOESA” (hereinafter referred to as the “Company”), which shall be written in English as “LG Display Co., Ltd.”

 

Article 2.

(Objectives)

The objectives of the Company shall be as follows:

 

  (1)

research, development, manufacturing, sales and marketing of displays and other related products utilizing the technologies, including, without limitation, thin-film transistor liquid crystal display (“TFT-LCD”), low-temperature poly-silicon liquid crystal display (“LTPS-LCD”) and organic light emitting display (“OLED”) technologies;

 

  (2)

research, development, manufacturing, sales and marketing of products utilizing solar energy;

 

  (3)

research, development, manufacturing, sales and marketing of certain components and equipments required for the development and manufacturing of the products and technologies described in the foregoing Paragraphs;


  (4)

real estate transaction and lease business; and

 

  (5)

any business and/or investment ancillary or incidental to the foregoing business.

 

Article 3.

(Location)

The Company shall have its principal office in Seoul, Korea, and may establish branch offices, sub-branch offices, and other offices and factories at places necessary by a resolution of the Board of Directors.

 

Article 4.

(Duration of Company)

The Company will continuously exist unless it is dissolved by a resolution of a General Meeting of Shareholders.

 

Article 5.

(Method of Public Notice)

Public notice by the Company shall be given on the Company’s website (http://www.lgdisplay.com). However, if public notice cannot be given on the Company’s website due to technical difficulties or other unavoidable circumstances, it shall be published in “Maeil Business Newspaper” and “The Chosun Ilbo”, both daily newspapers of general circulation published in Seoul.

CHAPTER II.         SHARES

 

Article 6.

(Total Number of Authorized Shares)

The total number of shares authorized to be issued by the Company shall be 500,000,000 shares.

 

Article 7.

(Face Value)

The face value per share to be issued by the Company is 5,000 Won.

 

2


Article 8.

(Electronic Registration of Shares and Rights that would otherwise be Indicated on Certificates of Preemptive Rights)

In lieu of issuing share certificates or certificates of preemptive rights, the Company shall electronically register the shares and rights that would otherwise be indicated on certificates of preemptive rights on an electronic registry of an electronic registration institution.

 

Article 9.

(Classes of Shares)

All shares to be issued by the Company shall be common shares in non-bearer form and preferred shares in non-bearer form.

 

Article 9-2.

(Number and Characteristics of Preferred Shares)

 

  (1)

Preferred shares to be issued by the Company shall be non-voting and the number thereof shall be 40,000,000.

 

  (2)

The dividend on a preferred share shall be not less than one percent (1%) per annum but not more than ten percent (10%) per annum of the par value of the share as determined by the Board of Directors at the time of issuance.

 

  (3)

In case the dividend ratio of the common shares exceeds that of the preferred shares, the additional dividend on preferred shares shall be declared by participating in distribution of dividend at same ratio of dividend on common shares with respect to such excess, at the time of distribution of dividend on common shares.

 

  (4)

If dividends on preferred shares for a fiscal year are not paid as prescribed above, such unpaid and accumulated amount shall be preferentially paid to the holders of preferred shares at the time of distribution of dividends for the following fiscal year.

 

  (5)

Preferred shares may be issued, by a resolution of the Board of Directors at the time of issuance, as convertible to common shares (“convertible preferred shares”). The conversion price shall be determined by the Board of Directors at the time of issuance, and shall not be lower than the par value of the shares nor higher than the issue price of the convertible preferred shares. If a conversion period or a duration of the convertible preferred shares (upon expiration of which convertible preferred shares are automatically converted) is to be set, such period or duration shall be determined by the Board of Directors at the time of issuance, and shall end within one (1) to ten (10) years from the issuance of the convertible preferred shares. With respect to the dividends on the shares issued upon conversion of the convertible preferred shares, the provisions of Article 11 and Article 43-2, Paragraph (4) shall apply mutatis mutandis.

 

3


  (6)

Preferred shares may be issued, by a resolution of the Board of Directors at the time of issuance, as redeemable within certain period of time with earnings (“redeemable preferred shares”). The redemption period shall be determined by the Board of Directors at the time of issuance and shall end within one (1) to ten (10) years from the issuance of the redeemable preferred shares. The Board of Directors shall determine the redemption price and the method of redemption, the source of which shall be earnings.

 

  (7)

Preferred shares may be issued, by a resolution of the Board of Directors at the time of issuance, with any or all of the features set forth above in Paragraphs (5) and (6).

 

  (8)

If the resolution not to pay the prescribed dividends on preferred shares is adopted at a General Meeting of Shareholders, the preferred shares shall have voting rights, starting with the first General Meeting of Shareholders following the General Meeting of Shareholders at which the resolution not to pay dividends on preferred shares was adopted, until the end of a General Meeting of Shareholders at which a resolution to pay dividends for such preferred shares is adopted.

 

  (9)

In case the Company issues new shares by rights issue or bonus issue, then the new shares issued with respect to the preferred shares shall be common shares in the case of rights issues and shall be the shares of the same class in the case of bonus issues.

 

Article 10.

(Preemptive Rights)

 

  (1)

The Company may issue additional shares with the resolution of the Board of Directors setting forth the detailed terms of the issue within the authorized share capital.

 

  (2)

The Company’s shareholders shall have preemptive rights to subscribe to new shares in proportion to their respective shareholding ratios; provided that the names and addresses of such shareholders shall be registered in the Register of Shareholders as of the date designated by the Company in the public notice made two (2) weeks prior thereto.

 

  (3)

Notwithstanding Paragraph (2) above, the Company may allocate new shares to persons other than existing shareholders of the Company by a resolution of the Board of Directors in any of the following cases, provided that the aggregate number of shares issued pursuant to items 1 through 7 below shall not exceed 20% of the total number of issued and outstanding shares:

 

  1.

Where the Company invites or cause underwriters to invite subscriptions for new shares;

 

  2.

Where the Company issues new shares through a method of general public offering under Article 165-6 of the Financial Investment Services and Capital Market Act (the “Capital Market Act”);

 

  3.

Where the Company allocates new shares to any member of its Employee Stockownership Association pursuant to Article 165-7 of the Capital Market Act or pursuant to the Employee Welfare Basic Act;

 

4


  4.

Where the Company issues new shares by exercise of stock options under Article 340-2 of the Commercial Code;

 

  5.

Where the Company issues new shares for the issuance of a depositary receipt (DR) under Article 165-16 of the Capital Market Act;

 

  6.

Where the Company issues new shares to corporations, institutional investors or domestic or overseas financial institutions, etc. for the achievement of the company’s operational objectives, such as improvement of financial structure, etc.; or

 

  7.

Where the Company issues new shares for the purpose of drawing foreign investment, when it deems necessary for its management; or

 

  8.

Where the Company issues new shares through a public offering or cause underwriters to underwrite the new shares and/or DR for the purpose of initial listing on the Korea Exchange and/or the New York Stock Exchange.

 

  (4)

If shares are not subscribed for as the result of a shareholder waiving or losing his/her pre-emptive right, or if fractional shares result from the allocation of new shares, such shares shall be disposed of in accordance with a resolution of the Board of Directors.

 

  (5)

The recipient of the new shares shall become a shareholder of the Company the succeeding day of the payment date.

 

Article 10-2

(Stock Options)

 

  (1)

The Company may grant stock options to its officers and employees (including the officers and employees of its affiliated company as defined in Article 542-3, Paragraph (1) of the Commercial Code; the same shall apply hereinafter) by a special resolution of the General Meeting of Shareholders pursuant to Article 340-2 of the Commercial Code, to the extent of not more than 15% of the total number of issued and outstanding shares; provided, however, that the Company may grant stock options to its officers and employees by a resolution of the Board of Directors to the extent of not more than 1% of the total number of issued and outstanding shares in accordance with the relevant laws and regulations. In this case, the shareholders or the Board of Directors may resolve to grant performance-linked stock options, linked with the Company’s performance or market index.

 

  (2)

The officers and employees, who have contributed, or have the capacity to contribute, to the establishment, management, overseas sales or technical improvement of the Company, may be granted stock options; provided, however, that those who are prohibited from being granted stock options under the applicable law and regulation may not be granted stock options.

 

  (3)

The shares to be issued by the Company to its officers or employees by the exercise of their stock options (which shall refer to the shares being the basis for calculation in case the Company pays the difference, either in cash or shares, between the exercise price of stock options and the market price) shall be common shares in non-bearer form.

 

5


  (4)

The terms and conditions, including features, exercise price, etc., of stock options shall be determined by a special resolution of the General Meeting of Shareholders or a resolution of the Board of Directors, pursuant to the applicable law and these Articles of Incorporation. The matters that are not set out to be decided by a resolution of the General Meeting of Shareholders or the Board of Directors under the applicable law or these Articles of Incorporation may be determined by the Board of Directors or a committee designated by the Board of Directors.

 

  (5)

Stock options may be exercised after at least 3 years, but not more than the number of years set by the relevant resolution of the General Meeting of Shareholders or the Board of Directors within 7 years, have elapsed from the date of the relevant resolution of the General Meeting of Shareholders or the Board of Directors. Any person with a stock option may exercise such stock option only if he/she has served the Company for at least two (2) years from the date of the relevant resolution of the General Meeting of Shareholders or the Board of Directors, unless otherwise specified in the relevant law.

 

  (6)

With respect to distribution of dividends for shares issued upon the exercise of stock options, Article 11 and Article 43-2, Paragraph (4) shall apply mutatis mutandis.

 

  (7)

The Company may cancel the grant of stock options by a resolution of the Board of Directors in any of the following cases:

 

  1.

Where an officer/employee of the Company voluntarily retires or resigns from his/her office after being granted stock options;

 

  2.

Where an officer/employee of the Company incurs substantial damages to the Company due to his/her willful misconduct or negligence;

 

  3.

Where the Company cannot respond to the exercise of an officer/employee’s stock options due to the Company’s liquidation or dissolution; or

 

  4.

Where any cause for cancellation set forth in the stock option agreement occurs.

 

Article 11.

(Record Date for Dividends on New Shares)

In case the Company issues new shares through rights issues, bonus issues or stock dividends, the new shares shall be deemed to have been issued at the end of the fiscal year immediately prior to the fiscal year during which the new shares are issued for purposes of distribution of annual dividends for such new shares.

 

Article 12.

(Suspension of Alteration of Register of Shareholders and Record Date)

 

  (1)

The Company shall suspend entry of any alterations into its register of shareholders with respect to shareholders’ rights from January 1 to January 15 of each year.

 

6


  (2)

The Company shall allow the shareholders who are registered in its register of shareholders as of December 31 of each year, to exercise their rights at an ordinary General Meeting of Shareholders held concerning the relevant fiscal year.

 

  (3)

When convening an extraordinary General Meeting of Shareholders or in any other necessary cases, in order to determine the person who shall exercise the right as shareholder, the Company may suspend entry of any alteration in the register of shareholders for a period not exceeding three (3) months as determined by a resolution of the Board of Directors or it may deem any shareholder whose name appears in the register of shareholders on a specified date, as determined by a resolution of the Board of Directors, to be the shareholder who shall be entitled to exercise such rights. The Company should give public notice thereof two weeks in advance.

 

Article 13.

(Transfer Agent)

 

  (1)

The Company shall retain a transfer agent for shares.

 

  (2)

The transfer agent, the location where its services are rendered and the scope of a transfer agent’s duties shall be determined by a resolution of the Board of Directors of the Company and shall be publicly notified.

 

  (3)

The Company shall keep the shareholders registry, or a duplicate thereof, at a location where a transfer agent renders its services. In addition, the Company shall cause the transfer agent to handle activities such as the electronic registration of shares, management of the shareholders registry and other related businesses.

 

  (4)

Those activities of a transfer agent set forth in Paragraph (3) above shall be performed in accordance with the Regulations for Securities Agency Business of the Transfer Agent.

 

Article 14.

[Deleted]

 

Article 15.

[Deleted]

 

7


CHAPTER II-2.         BONDS

 

Article 15-2.

(Issuance of Convertible Bonds)

 

  (1)

The Company may issue convertible bonds to persons other than its shareholders by a resolution of the Board of Directors in any of the following cases, to the extent that the aggregate par value amount of the convertible bonds (plus any previously issued and outstanding convertible bonds and bonds with warrants) does not exceed two trillion five hundred billion Won (2.5 trillion Won):

 

  1.

Where the Company issues convertible bonds through a general public offering;

 

  2.

Where the Company issues convertible bonds for the purpose of drawing foreign investment, when it deems necessary for its management;

 

  3.

Where the Company issues convertible bonds to a domestic or overseas financial institution for an urgent need for funds; or

 

  4.

Where the Company issues convertible bonds in foreign countries in accordance with Article 165-16 of the Capital Market Act.

 

  (2)

The convertible bonds referred to in Paragraph (1) above may be issued by the Board of Directors with partial conversion rights under which the right of the bondholders to demand conversion may be limited to a certain percentage of the total amount of convertible bonds.

 

  (3)

The classes of shares to be issued upon conversion shall be common shares. The conversion price shall not be lower than the par value of the Company’s shares as determined by the Board of Directors at the time of issuance of the relevant convertible bonds.

 

  (4)

The period during which conversion may be requested shall be from the date one (1) month after the date of issuance of the relevant convertible bonds to the date one day prior to the redemption date of the bonds; provided, that the Board of Directors may, by its resolution, adjust the exercise period for convertible bonds within the above period.

 

  (5)

With respect to the dividends on the shares to be issued upon conversion, Article 11 and Article 43-2, Paragraph (4) shall apply mutatis mutandis.

 

Article 15-3.

(Issuance of Bonds with Warrants)

 

  (1)

The Company may issue bonds with warrant to persons other than its shareholders by a resolution of the Board of Directors in any of the following cases, to the extent that the aggregate par value amount of the bonds with warrant (plus any previously issued and outstanding convertible bonds and bonds with warrants) does not exceed two trillion five hundred billion Won (2.5 trillion Won):

 

  1.

Where the Company issues bonds with warrant through a general public offering;

 

  2.

Where the Company issues bonds with warrant for the purpose of drawing foreign investment, when it deems necessary for its management;

 

  3.

Where the Company issues bonds with warrant to a domestic or overseas financial institution for an urgent need for funds; or

 

  4.

Where the Company issues bonds with warrant in foreign countries in accordance with Article 165-16 of the Capital Market Act.

 

8


  (2)

The aggregate price of new shares which may be subscribed for by the holders of warrants shall be determined by the Board of Directors, but shall not exceed the aggregate par value of the bonds with warrants.

 

  (3)

The classes of shares to be issued upon exercise of warrant shall be common shares. The exercise price shall not be lower than the par value of the Company’s shares as determined by the Board of Directors at the time of issuance of the relevant bonds with warrant.

 

  (4)

The period during which warrant may be exercised shall be from the date one (1) month after the date of issuance of the relevant bonds with warrant to the date one day prior to the redemption date of the bonds; provided, that the Board of Directors may, by its resolution, adjust the exercise period for bonds with warrant within the above period.

 

  (5)

With respect to the dividends on the shares to be issued upon exercise of warrant, Article 11 and Article 43-2, Paragraph (4) shall apply mutatis mutandis.

 

Article 15-4.

(Electronic Registration of Bonds and Warrant Rights that would otherwise be Indicated on Certificates)

In lieu of issuing bond or warrant certificates, the Company shall electronically register the bonds and warrant rights that would otherwise be indicated on certificates on an electronic registry of an electronic registration institution.

 

Article 15-5.

(Provisions Applicable to Bond Issuance)

Article 13 shall apply mutatis mutandis to issuance of bonds.

CHAPTER III.         GENERAL MEETINGS OF SHAREHOLDERS

 

Article 16.

(Time for convening of General Meetings of Shareholders)

 

  (1)

General Meetings of the Shareholders of the Company shall be of two kinds: ordinary and extraordinary.

 

  (2)

Ordinary General Meetings of Shareholders shall be held within three (3) months after the end of each fiscal year and Extraordinary General Meetings of Shareholders may be convened whenever deemed necessary.

 

9


Article 17.

(Convening of General Meetings of Shareholders)

 

  (1)

Unless otherwise provided for in the relevant laws and regulations, a General Meeting of Shareholders shall be convened by the Company’s Representative Director pursuant to a resolution of the Board of Directors. On the occurrence of a vacancy or absence of the Representative Director, Article 29, Paragraph (3) hereof shall apply, mutatis mutandis.

 

  (2)

A General Meeting of Shareholders may be held at the head office of the Company, Paju plant or at any other place as designated by the Board of Directors.

 

  (3)

A notice for convening a General Meeting of Shareholders, which sets forth the time, date, place and agenda of the meeting, shall be sent to each shareholder, either in a written or an electronic form, at least two (2) weeks prior to the date of the meeting.

 

  (4)

A notice to shareholders holding not more than one percent of the total number of issued and outstanding shares with voting rights may be replaced by public notices made two weeks prior to the General Meeting of Shareholders, either made at least twice in the “Maeil Business Newspaper” and “The Chosun Ilbo”, both published in Seoul, or in the electronic disclosure system operated by the Financial Supervisory Service or the Korea Exchange. The public notice of a meeting shall include a statement that the General Meeting of Shareholders will be held and the venue, date and the agenda of such meeting.

 

Article 18.

(Chairman of Meeting)

The Representative Director or a Director designated by the Representative Director shall serve as Chairman of the General Meeting of Shareholders. On the occurrence of a vacancy or absence of the Representative Director, Article 29, Paragraph (3) hereof shall apply, mutatis mutandis.

 

Article 18-2.

(Maintenance of Order by the Chairman)

 

  (1)

The chairman of a General Meeting of Shareholders may order persons who intentionally speak or behave obstructively or who disturb the proceedings of the meeting to stop a speech or to leave the place of the meeting.

 

  (2)

The chairman of a General Meeting of Shareholders may restrict the time and number of speeches of a shareholder as deemed necessary for the purpose of efficient progress in the proceeding of the meeting.

 

10


Article 19.

(Method of Resolution)

Except as otherwise provided in the applicable laws and the Articles of Incorporation of the Company, all resolutions of a General Meeting of Shareholders shall be adopted by the affirmative votes of the majority of shareholders present at the meeting; provided that, such votes shall represent at least one fourth (1/4) of total number of issued and outstanding shares of the Company.

 

Article 20.

(Exercise of Voting Rights)

 

  (1)

Each share shall have one (1) voting right.

 

  (2)

A shareholder may exercise his/her vote through a proxy. In this case, the proxy holder shall file with the Company document evidencing authority to act as a proxy no later than the beginning of the General Meeting of Shareholders.

 

  (3)

The Company shall not adopt the cumulative voting system provided under Article 382-2 of the Commercial Code.

 

Article 21.

(Restrictions on the Exercise of Voting Rights by Cross Ownership)

If the Company, its parent company and subsidiaries, or any of its subsidiaries hold shares exceeding one-tenth (1/10) of the total number of issued shares of another company, such other company may not exercise any voting rights with respect to the shares of the Company which it holds.

 

Article 22.

(Split Exercise of Votes)

 

  (1)

A shareholder, holding two (2) or more votes, who wishes to split his/her votes, shall notify the Company to that effect and the reasons thereof by writing no later than the third day preceding the date set for the General Meeting of Shareholders.

 

  (2)

The Company may refuse to allow the shareholder to split his/her votes unless the shareholder acquired the shares in trust or otherwise holds the shares for and on behalf of some other person.

 

Article 23.

(Minutes of the Meeting)

The substance of the course of the proceedings of the General Meeting of Shareholders and the results thereof shall be recorded in the minutes and shall be kept at the head office and branches of the Company, after being affixed with the names and seal impressions or signatures of the chairman of the General Meeting of Shareholders as well as the Directors present.

 

11


Article 24.

[Deleted]

CHAPTER IV.         DIRECTORS AND BOARD OF DIRECTORS

 

Article 25.

(General Authority)

Except as otherwise required by mandatory provisions of Korean law, the responsibility for the management, direction and control of the Company will be vested in the Board of Directors of the Company.

 

Article 26.

(Number of Directors)

The Company shall have at least five (5) and up to seven (7) Directors, more than half of whom must be outside1 Directors.

 

Article 27.

(Election of Directors)

Directors shall be elected at a General Meeting of Shareholders of the Company.

 

Article 27-2.

(Nomination of Candidates for Outside Directors)

 

  (1)

The Company’s Outside Director Nomination Committee shall recommend candidates for outside Directors, from those who are qualified under the Korean Commercial Code (“KCC”) and other applicable provisions.

 

  (2)

Any details concerning the nomination of candidates for outside Directors and deliberation on requirements of such candidates shall be determined by the Company’s Outside Director Nomination Committee.

 

 

1 

The term “Outside Director” used throughout the AOI has the meaning given by the Capital Market Act of Korea. The qualifications required of an “independent director” by the NYSE listing codes do not have to be set forth in word in the AOI, as long as a person(s) with such qualifications sits on the board.

 

12


Article 28.

(Terms of Directors)

Starting from the appointment, the term of office of Directors shall not exceed the close of the ordinary General Meeting of Shareholders that is convened for the period for the settlement of accounts for the third (3rd) year from the appointment.

 

Article 29.

(Appointment of Representative Director and Duties)

 

  (1)

The Representative Director of the Company shall be appointed by a resolution of the Board of Directors’ meeting and the Representative Director shall represent the Company and manage all matters of the Company.

 

  (2)

If two (2) or more Representative Directors are appointed, each shall represent the Company.

 

  (3)

On the occurrence of a vacancy or absence of the Representative Director, the person authorized in such order of priority as determined by the Regulations of the Board of Directors or the person separately determined by the Board of Directors shall perform his/her duties.

 

Article 30.

(Meetings of the Board of Directors)

 

  (1)

Meetings of the Board of Directors shall be convened by the Chairman of the Board of Directors or the person designated by the Regulation of the Board of Directors.

 

  (2)

Meetings of the Board of Directors shall be convened no less frequently than on a quarterly basis. The persons entitled to convene a Meeting of the Board of Directors shall decide the meeting date and send a notice thereof to the Directors in writing, through electronic communication or orally at least twelve(12) hours prior to such meeting; provided that, when the consent of all the Directors has been obtained, a meeting of the Board of Directors may be held anytime without conforming to these procedures.

 

  (3)

Meetings of the Board of Directors may be conducted in the English language and shall be translated into the Korean language by an interpreter, if necessary.

 

  (4)

The Chairman of the Board of Directors shall be elected by the Board of Directors.

 

  (5)

Meetings of the Board of Directors shall be held in Korea, unless otherwise determined by the Board of Directors.

 

Article 31.

(Resolutions of the Board of Directors)

 

  (1)

The quorum for the Meeting of the Board of Directors of the Company shall require the presence of the majority of Directors in office.

 

13


  (2)

Resolutions of a meeting of the Board of Directors shall be adopted by the affirmative votes of a majority of the Directors present.

 

  (3)

The Board of Directors may allow all or part of the Directors in office to exercise his/her and/or their voting rights by telecommunication means through which they may transmit and receive voices at the same time without attending a meeting of the Board of Directors in person. In such case, the concerned Director(s) shall be deemed as having attended the meeting of the Board of Directors in person.

 

  (4)

Each member of the Board of Directors shall have one (1) voting right; provided, however, that any person who has special interests concerning a resolution of the Board of Directors may not exercise his/her voting right.

 

Article 32.

(Filling of Vacancy)

 

  (1)

Any vacancy in the office of Director shall be filled by resolution of a General Meeting of Shareholders; provided, however, that if the number of Directors required by Article 26 hereof is met and there is no difficulty in the administration of business, the vacancy may be left un-filled.

 

  (2)

In case where the number of outside Directors required by Article 26 hereof is not met for reasons of resignation, death, etc., the vacancy should be filled at the first General Meeting of Shareholders to be convened after occurrence of such reason.

 

Article 33.

(Minutes of the Board of Directors’ Meeting)

 

  (1)

The proceedings of a Board of Directors’ meeting shall be recorded in the minutes.

 

  (2)

The minutes shall set forth the agenda, the course of the proceedings and the results thereof, the opposing person(s) and the reasons for such opposition, and the chairman and all Directors present shall affix their names and seals or signatures to the minutes. The minutes shall be kept in the head office of the Company.

 

Article 34.

(Committees)

 

  (1)

The Company shall establish following committees within the Board of Directors.

 

  1.

Audit Committee

 

  2.

Outside Director Nomination Committee

 

14


  3.

Other committees as deemed necessary by the Board of Directors

 

  (2)

Details on composition, power and operation of each committee shall be determined by a resolution of the Board of Directors.

 

  (3)

Articles 30 (2), 31 and 33 shall apply mutatis mutandis in respect of the foregoing committees.

 

Article 35.

(Remuneration and Severance Pay of Directors)

 

  (1)

The total amount of remuneration for the Directors shall be determined by a resolution of the General Meeting of Shareholders.

 

  (2)

The severance pay for the Directors shall be made in accordance with the Regulations of Severance Payment to Directors as separately determined by a resolution of the General Meeting of Shareholders.

 

Article 36.

[Deleted]

CHAPTER IV-II.         AUDIT COMMITTEE

 

Article 36-2.

(Composition of Audit Committee)

 

  (1)

The Company shall have an Audit Committee in lieu of the statutory auditors in accordance with Article 34 hereof.

 

  (2)

The Audit Committee shall consist of three (3) outside Directors.

 

  (3)

The Company shall appoint the members of the Audit Committee from the Directors of the Company, after having appointed such Directors as Directors of the Company at a General Meeting of Shareholders; provided, however, that, one (1) of the members of the Audit Committee shall be a Director appointed as a Director to be appointed as a member of the Audit Committee, separate from other Directors appointed, at the General Meeting of Shareholders.

 

  (4)

When the shareholders appoint a member of the Audit Committee at a General Meeting of Shareholders, any shareholder who holds more than 3% of the total number of voting shares issued by the Company shall not exercise the voting rights of the shares in excess thereof.

 

15


  (5)

The Audit Committee shall appoint, by its resolution, a person to represent the committee.

 

Article 36-3.

(Duties of Audit Committee)

 

  (1)

The Audit Committee shall examine the accounts and businesses of the Company.

 

  (2)

The Audit Committee may request the Board of Directors to convene an extraordinary General Meeting of Shareholders by submitting documents stating the agenda and reasons for such convocation.

 

  (3)

The Audit Committee may request the Company’s subsidiary to report the details of the operation, if deemed necessary for performance of its duties. In such a case, if the subsidiary fails to immediately report the details or if it is necessary to confirm the contents of the report, the Audit Committee may investigate the subsidiary’s business operation and financial status.

 

  (4)

The Audit Committee shall dispose any matters delegated by the Board of Directors, as provided in the Audit Committee Charter resolved by the Board of Directors, other than those set forth in Paragraphs (1) through (3) above.

 

Article 36-4.

(Auditor’s Records)

The Audit Committee shall prepare an auditor’s record with respect to auditing and shall record the substance and results of the audit in the auditors’ record, on which the names and seals or signatures of the members of the Audit Committee who have performed such audit shall be affixed.

CHAPTER V.        ACCOUNTING

 

Article 37.

(Fiscal Year)

The fiscal year of the Company shall commence on January 1 of each year and end on December 31 (of the same year).

 

Article 38.

[Deleted]

 

Article 39.

[Deleted]

 

16


Article 40.

[Deleted]

 

Article 41.

(Preparation and Maintenance of Financial Statements and Business Report)

 

  (1)

The Representative Director shall prepare the following documents, supplementary documents thereto and the business report, and submit such documents to the Audit Committee for audit six (6) weeks prior to the day set for the ordinary General Meeting of Shareholders. The Representative Director, or if the Company has Joint Representative Directors, the Chief Executive Officer and Joint Representative Director, shall submit the following documents and the business report to the ordinary General Meeting of Shareholders for approval:

 

  1.

Balance sheet;

 

  2.

Profit and loss statement; and

 

  3.

Other documents prescribed by the Enforcement Decree of the KCC that present the Company’s financial position and business performance.

 

  (2)

If the Company is required to prepare consolidated financial statements under the Enforcement Decree of the KCC, the documents under Paragraph (1) above shall include those prepared on a consolidated basis, respectively.

 

  (3)

The Audit Committee shall submit the auditors’ report to all Directors one (1) week prior to the day set for the ordinary General Meeting of Shareholders.

 

  (4)

The Representative Director shall keep on file, from one (1) week before the day set for the ordinary General Meeting of Shareholders, the documents described in Paragraph (1) above and supplementary documents together with the business report and the auditors’ report at the head office of the Company for five (5) years and certified copies of all of such documents at the branches of the Company for three (3) years.

 

  (5)

The Representative Director shall give public notice of the balance sheet and the external auditor’s opinion immediately after the documents referred to in Paragraph (1) above have been approved at the General Meeting of Shareholders.

 

Article 41-2.

(Appointment of External Auditor)

The Company shall appoint an external auditor pursuant to the Act on External Audit of Stock Companies, Etc. and shall report such fact at the first ordinary General Meeting of Shareholders to be convened after the appointment or shall otherwise notify or publicly announce such fact to the shareholders as prescribed in the Enforcement Decree of the Act on External Audit of Stock Companies, Etc.

 

17


Article 42

(Appropriation of Earnings)

The Company shall dispose of the unappropriated retained earnings as of the end of each fiscal year as follows:

 

  1.

Legal reserve;

 

  2.

Other statutory reserves;

 

  3.

Dividends;

 

  4.

Discretionary reserve; and

 

  5.

Other appropriation of retained earnings.

 

Article 42-2.

[Deleted]

 

Article 43.

(Dividends)

 

  (1)

Dividends may be paid in either cash or shares.

 

  (2)

In case dividends are distributed in shares, if the Company has issued several classes of shares, such distribution may be made through shares of different classes by a resolution of a General Meeting of Shareholders.

 

  (3)

Dividends in Paragraph (1) above shall be paid to the shareholders or pledgees registered in the shareholders registry of the Company as of the end of each fiscal year.

 

Article 43-2.

(Interim Dividends)

 

  (1)

The Company may pay interim dividends in accordance with Article 462-3 of the Commercial Code to its shareholders who are registered in the shareholder’s registry as of 00:00 a.m. on July 1 of the relevant fiscal year. Such interim dividends shall be made in cash.

 

  (2)

The interim dividends mentioned in Paragraph (1) above shall be decided by a resolution of the Board of Directors, which resolution shall be made within forty-five (45) days from the date mentioned in Paragraph (1) above.

 

  (3)

The maximum amount to be paid as interim dividends shall be calculated by deducting the following amounts from the net asset amounts recorded in the balance sheet of the fiscal year immediately prior to the fiscal year concerned:

 

  1.

Paid in capital of the company for the fiscal year immediately prior to the fiscal year concerned;

 

18


  2.

The aggregate amount of capital reserves and legal reserves which had been accumulated up until the fiscal year immediately prior to the fiscal year concerned;

 

  3.

The amount which was resolved to be distributed as dividends at an ordinary General Meeting of Shareholders of the fiscal year immediately prior to the fiscal year concerned;

 

  4.

Voluntary reserves which had been accumulated for specific purposes in accordance with the relevant provisions of the Articles of Incorporation or by resolution of the General Meetings of Shareholders until the fiscal year immediately prior to the fiscal year concerned;

 

  5.

Aggregate earned surplus reserves to be accumulated for the fiscal year concerned as a result of the interim dividends; and

 

  (4)

If the Company has issued new shares (including those shares issued by way of conversion of reserves into capital stock, stock dividends, request of conversion of convertible bonds or exercise of warrants) prior to the date set forth in Paragraph (1) above, but after the commencement date of the fiscal year concerned, the new shares shall be deemed to have been issued at the end of the fiscal year immediately prior to the fiscal year concerned for the purpose of interim dividends.

 

  (5)

When distributing interim dividends, the same dividend ratio as that of the common shares of the Company shall be applied to the preferred shares.

 

Article 44.

(Prescription Period for Claim for Payment of Dividends)

 

  (1)

The right to dividends shall be extinguished by prescription if the right is not exercised for five (5) years.

 

  (2)

After the expiration of the prescription period set forth in Paragraph (1), unclaimed dividends shall revert to the Company.

ADDENDA

1. These Articles of Incorporation shall be effective from June 23, 2004, except for the Article 17, Paragraph (4), Article 41, Paragraph (2), Article 42-2, Article 43-2 which shall be effective upon the shares of the Company being listed on the Korea Exchange.

 

19


2. Notwithstanding Addudum 1. above, the Company shall satisfy the requirements under latter part of Article 26, Article 34 and Chapter IV-II of these amended Articles of Incorporation by the close of the first Annual (Ordinary) General Meeting of Shareholders to be convened after the amendment of these Articles of Incorporation. Until the composition of the Audit Committee under these amended Articles of Incorporation, the Company shall have at least one (1) statutory auditor and the current statutory auditor(s) of the Company shall have the same duty and rights as the statutory auditor(s) pursuant to the Commercial Code and the Articles of Incorporation prior to the amendment.

3. The outside Directors to be elected until the close of the first Annual (Ordinary) General Meeting of Shareholders to be convened after the amendment of these Articles of Incorporation, shall be deemed to have been nominated by the Outside Director Nomination and Corporate Governance Committee pursuant to Article 27-2; provided, however, that the outside Directors shall be nominated by the Outside Director Nomination and Corporate Governance Committee once such Committee has been composed of even before the close of such General Meeting of Shareholders.

ADDENDA (as of March 23, 2005)

These Articles of Incorporation shall be effective from March 23, 2005.

ADDENDA (as of February 28, 2007)

These Articles of Incorporation shall be effective from February 28, 2007.

ADDENDA (as of February 29, 2008)

These Articles of Incorporation shall be effective from March 3, 2008.

ADDENDA (as of March 13, 2009)

These Articles of Incorporation shall be effective from March 13, 2009.

ADDENDA (as of March 12, 2010)

These Articles of Incorporation shall be effective from March 12, 2010.

ADDENDA (as of March 11, 2011)

These Articles of Incorporation shall be effective from March 11, 2011.

 

20


ADDENDA (as of March 8, 2013)

These Articles of Incorporation shall be effective from March 8, 2013.

ADDENDA (as of March 15, 2019)

These Articles of Incorporation shall be effective from March 15, 2019, except for the amended provisions of Article 8, Article 13, Article 14, Article 15-4 and Article 15-5, which shall be effective from the date the Act on Electronic Registration of Stocks, Bonds, Etc. takes effect.

ADDENDA (as of March 23, 2021)

These Articles of Incorporation shall be effective from March 23, 2021.

 

21


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘20-F’ Filing    Date    Other Filings
Filed on:4/29/21
3/23/216-K
For Period end:12/31/20SD
3/15/196-K
3/8/136-K
3/11/116-K
3/12/106-K
3/13/096-K
3/3/08
2/29/086-K
2/28/076-K
3/23/056-K
6/23/04
5/4/04
3/19/04
3/21/01
8/11/00
 List all Filings 


4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/30/14  Citibank, N.A./ADR                F-6 POS     7/30/14    2:401K LG Display Co., Ltd.              E-Data Systems, Inc./FA
 4/16/08  LG Display Co., Ltd.              20-F       12/31/07    6:1.9M                                   Donnelley … Solutions/FA
11/28/07  LG Display Co., Ltd.              F-6EF      11/28/07    5:245K                                   E-Data Systems, Inc./FA
 7/13/04  LG Display Co., Ltd.              F-1/A                  5:582K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-21-138471   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 2:10:03.1am ET